Recurrent or aggressive bladder cancer. Indications for adjuvant intravesical therapy.

Badalament, R A; Ortolano, V; Burgers, J K

Badalament, R A; Ortolano, V; Burgers, J K.

Affiliation

Badalament RA; Division of Urology, Ohio State University, Columbus.

Urol Clin North Am ; 19(3): 485-98, 1992 Aug.

Article in En | MEDLINE | ID: mdl-1636233

Subject(s)

Carcinoma, Transitional Cell/therapy; Neoplasm Recurrence, Local/therapy; Urinary Bladder Neoplasms/therapy; Administration, Intravesical; Antineoplastic Agents/administration & dosage; BCG Vaccine/administration & dosage; Carcinoma in Situ/therapy; Carcinoma, Transitional Cell/epidemiology; Carcinoma, Transitional Cell/genetics; Combined Modality Therapy; Humans; Neoplasm Staging; Ploidies; Risk Factors; Urinary Bladder Neoplasms/epidemiology; Urinary Bladder Neoplasms/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Neoplasm Recurrence, Local Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Urol Clin North Am Year: 1992 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links